Abstract
Management of hyperglycaemia in patients during parenteral nutrition (PN) remains difficult in clinical practice. Yet, hyperglycaemia cannot be left untreated regarding its potential fatal adverse outcomes. At the opposite, the control of glycaemia can also have adverse effect as hypoglycaemia with severe consequences for the patient. The management of PN should be performed on a multidisciplinary basis and the experience of the medical staff is an essential element in order to obtain the targeted glucose control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
